Tybost Drug Interactions
Currently displaying 243 drugs known to have a moderate interaction with Tybost (cobicistat).
Moderate interactions with Tybost (cobicistat)
Note: Showing generic names only.
A
- abacavir
- abametapir topical
- adefovir
- ado-trastuzumab emtansine
- afatinib
- albendazole
- aliskiren
- almotriptan
- alpelisib
- amitriptyline
- amlodipine
- amoxapine
- amphetamine
- amprenavir
- aprepitant
- aripiprazole
- armodafinil
- artesunate
- asciminib
- atomoxetine
- atorvastatin
- avatrombopag
B
- bedaquiline
- belzutifan
- betamethasone
- betrixaban
- binimetinib
- bortezomib
- budesonide nasal
- buprenorphine
- buspirone
C
- cabazitaxel
- cannabis
- carvedilol
- cenobamate
- cerivastatin
- cevimeline
- chloroquine
- chlorpheniramine
- chlorpromazine
- ciclesonide
- ciclesonide nasal
- cinacalcet
- clarithromycin
- clindamycin
- clomipramine
- clonazepam
- clorazepate
- clotrimazole
- clozapine
- codeine
- cortisone
D
- dabigatran
- dabrafenib
- darolutamide
- delavirdine
- desipramine
- dexamethasone
- dexamethasone nasal
- dexamethasone ophthalmic
- dexfenfluramine
- dextromethorphan
- diazepam
- didanosine
- digoxin
- diltiazem
- diphenhydramine
- dofetilide
- doxazosin
- doxepin
- droperidol
- duloxetine
- dutasteride
E
- echinacea
- efavirenz
- emtricitabine
- enfuvirtide
- eravacycline
- erlotinib
- eslicarbazepine
- estazolam
- estradiol
- ethinyl estradiol
- ethosuximide
- etonogestrel
- etrasimod
- etravirine
F
- felodipine
- fenfluramine
- fluconazole
- fludrocortisone
- flunisolide
- flunisolide nasal
- fluorometholone ophthalmic
- fluoxetine
- fluphenazine
- flurazepam
- fluvastatin
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fostemsavir
G
H
I
K
L
- lacosamide
- lamivudine
- leniolisib
- levamlodipine
- levobupivacaine
- levonorgestrel
- lidocaine
- lonapegsomatropin
- loteprednol ophthalmic
- lusutrombopag
M
- maprotiline
- maraviroc
- medroxyprogesterone
- methamphetamine
- methotrimeprazine
- metoclopramide
- metoprolol
- mexiletine
- mibefradil
- miconazole
- midodrine
- mirtazapine
- modafinil
- momelotinib
- mometasone
- mometasone nasal
N
- nafcillin
- naldemedine
- nebivolol
- nelfinavir
- nevirapine
- nicardipine
- nifedipine
- nintedanib
- nisoldipine
- nitisinone
- norethindrone
- norgestrel
- nortriptyline
O
P
- paclitaxel
- paclitaxel protein-bound
- paricalcitol
- paroxetine
- perphenazine
- pexidartinib
- pindolol
- pitavastatin
- pitolisant
- pomalidomide
- posaconazole
- pravastatin
- prednisolone
- prednisolone ophthalmic
- prednisone
- prochlorperazine
- promethazine
- propoxyphene
- propranolol
- protriptyline
Q
R
- raltegravir
- ramelteon
- regorafenib
- repaglinide
- resmetirom
- revefenacin
- rilpivirine
- risperidone
- ritlecitinib
- ritonavir
- roflumilast topical
- romidepsin
- rosuvastatin
- rucaparib
- rufinamide
S
- saquinavir
- saxagliptin
- sertraline
- sirolimus topical
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- stavudine
- stiripentol
- sufentanil
- sulfinpyrazone
- sunitinib
T
- tadalafil
- talazoparib
- tamoxifen
- tasimelteon
- tecovirimat
- telithromycin
- tenofovir
- tenofovir alafenamide
- tetrabenazine
- timolol
- tipranavir
- tolterodine
- tovorafenib
- tramadol
- trazodone
- tretinoin
- triamcinolone nasal
- triamcinolone ophthalmic
- trimipramine
- trofinetide
- troleandomycin
- tucatinib
V
W
Z
Tybost disease interactions
There is 1 disease interaction with Tybost (cobicistat) which include:
More about Tybost (cobicistat)
- Tybost consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antiviral boosters
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.